ACE Report Cover
Radiostereometric analysis: no additional benefit of Unique femoral stem compared to AGB-I
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
Lingua
Download Download Download
Scaricare
Cite this Report Cite this Report Cite this Report
Citare
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ Preferiti
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
Lingua
Download Download Download
Scaricare
Cite this Report Cite this Report Cite this Report
Citare
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ Preferiti
ARTHROPLASTY
Radiostereometric analysis: no additional benefit of Unique femoral stem compared to AGB-I .

OrthoEvidence Journal (OE Journal) - ACE Report

OE Journal. 2014;2(13):9 Acta Orthop. 2014 Apr;85(2):152-8

100 patients with primary or secondary osteoarthritis were randomized to investigate any additional benefits associated with the use of the Unique customized stem compared with the conventional ABG-I stem. Patients were evaluated over 5 years using radiostereometric (RSA). The evidence presented in this study revealed no improvement in long-term mechanical stability associated with the Unique stem. It is important to note that no included patients presented with abnormal geometry of the upper femur for which the custom stems are developed.


Dettagli sul finanziamento della pubblicazione +
Finanziamento:
Non-funded
Conflitti:
Other

Rischio di pregiudizio

6,5/10

Criteri di segnalazione

17/20

Indice di fragilità

N/A

Was the allocation sequence adequately generated?

Was allocation adequately concealed?

Blinding Treatment Providers: Was knowledge of the allocated interventions adequately prevented?

Blinding Outcome Assessors: Was knowledge of the allocated interventions adequately prevented?

Blinding Patients: Was knowledge of the allocated interventions adequately prevented?

Was loss to follow-up (missing outcome data) infrequent?

Are reports of the study free of suggestion of selective outcome reporting?

Were outcomes objective, patient-important and assessed in a manner to limit bias (ie. duplicate assessors, Independent assessors)?

Was the sample size sufficiently large to assure a balance of prognosis and sufficiently large number of outcome events?

Was investigator expertise/experience with both treatment and control techniques likely the same (ie.were criteria for surgeon participation/expertise provided)?

Sì = 1

Incerto = 0,5

Non rilevante = 0

No = 0

La valutazione dei criteri di segnalazione valuta la trasparenza con cui gli autori riportano le caratteristiche metodologiche e sperimentali dello studio all'interno della pubblicazione. La valutazione è suddivisa in cinque categorie che vengono presentate di seguito.

3/4

Aleatorización

3/4

Medición de resultados

4/4

Inclusión / exclusión

4/4

Descripción de la terapia

3/4

Estadísticas

Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbé KA. J Clin Epidemiol. 1992;45:255-65

L'Indice di Fragilità è uno strumento che aiuta l'interpretazione dei risultati significativi, fornendo una misura della forza di un risultato. L'Indice di Fragilità rappresenta il numero di eventi consecutivi che devono essere aggiunti a un risultato dicotomico per rendere il risultato non più significativo. Un numero piccolo rappresenta un risultato più debole, mentre un numero grande rappresenta un risultato più forte.

Perché questo studio era necessario ora?

Micromovements along the implant-bone interface are associated with loosening of uncemented femoral stem implants. Generally speaking, a 40 micrometer interfacial motion contributes to partial bone ingrowth, and those exceeding 150 micrometers completely disrupts ingrowth. Mechanical stability of the implant is influenced by patient- and implant-specific factors, and uncemented customized femoral stems are hypothesized to promote superior mechanical fixation compared to standard implants. This study was needed to conduct radiostereometric (RSA) follow-up on a 5 year RCT that evaluated the Unique customized stem (Scandinavian Customized Prosthesis [SCP]), against a conventional ABG-I stem.

Qual era la domanda di ricerca principale?

What is the comparative migration between the use of the Unique customized stem, and the conventional ABG-I stem, as evaluated using radiostereometric (RSA) over 5 years?

Caratteristiche dello studio +
Population:
100 patients with primary or secondary osteoarthritis, who were classified as having regular upper femoral anatomy. Following the femoral surgery, all patients underwent the same rehabilitation protocol: all patients were allowed full weight bearing immediately after surgery but were advised to use crutches for 8 weeks. (n=80 at final follow-up)
Intervention:
Unique Femoral Stem Group: Patients underwent surgery in lateral decubitus position, and a direct lateral approach. The custom design of the Unique stem was based on CT scans of the proximal femur, and developed using a semiautomatic computer algorithm.(n=50; 41 at 5 years)
Comparison:
ABG-I Stem Group: Patients underwent surgery in lateral decubitus position, and a direct lateral approach. The ABG-I stem had an anatomical press-fit design with plasma-sprayed HA layer with a macro-relief surface on the proximal third. (n=50; 39 at 5 years)
Outcomes:
Patients underwent radiostereometric analysis (RSA), and were assessed according to the Merle d’ Aubigne (MdA) score for joint mobility, pain, and ability to walk. VAS pain, and satisfaction were noted in each patient. Micromovements of the stem were measured as rotations around the translations along 3 orthogonal axes.
Methods:
RCT
Time:
Patients were evaluated at 3, 6, 12, 24, and 60 months.
Quali erano i risultati importanti?
  • Motion between the 2 types of stems were comparable (all p>0.05): The median subsidence was -0.03mm for the ABG-I stem compared to -0.13mm for the Unique stem (p=0.15). Mean retroversion was 0.15 degrees compared to -0.08 degrees in the ABG-I and Unique stems respectively (p=0.41).
  • Time was noted as a factor that was significantly related to: translation along the y (p=0.02) and z (p<0.01) axes and rotation around the x (p=0.03) and z (p=0.01) axes.
  • A single Unique stem subsided 5.3mm within the first year and then stabilized. Further analysis revealed no loosening.
  • Mean preoperative Merle d’Aubigne score was 11 in the ABG-I group compared to 10 in the Unique groups. At final follow-up of 5 years, mean scores in both groups was 17.
  • Preoperative pain decreased from 6.5 to 1.1 in the ABG-I group and from 6.5 to 1.0 in the Unique group. Satisfaction was 1.1 and 0.7 respectively at 5 years.
  • No hips were revised over the 5 years; there were, however, 5 complications: ABG –I group had 2 instances of DVT and 2 early dislocations. The Unique group had 1 common peroneal nerve dysfunction.
Che cosa devo ricordare di più?

Radiostereometric analysis (RSA) between the use of the Unique customized stem ((Scandinavian Customized Prosthesis (SCP)), and the conventional ABG-I stem revealed no improvement in long-term mechanical stability associated with the Unique stem.

Come influenzerà l'assistenza ai miei pazienti?

The evidence presented in this study indicated no additional benefits associated with the use of the Unique customized stem ((Scandinavian Customized Prosthesis (SCP)). It is important to note that none of the included patients presented with abnormal geometry of the upper femur for which the custom stems were developed.

DISCLAIMER

Il contenuto di questa pagina è solo a scopo informativo e non intende sostituire la consulenza, la diagnosi o il trattamento medico professionale. Se ha bisogno di cure mediche, si rivolga sempre al suo medico o al pronto soccorso più vicino. Le opinioni, le convinzioni e i punti di vista espressi dalle persone sui contenuti presenti in questa pagina non riflettono le opinioni, le convinzioni e i punti di vista di OrthoEvidence.

0 di 4 articoli mensili GRATUITI sbloccati
Ha raggiunto il suo limite di 4 visualizzazioni di articoli gratuiti questo mese

Accesso a OrthoEvidence a soli 1,99 dollari a settimana.

Rimanga in contatto con le ultime prove. Può disdire in qualsiasi momento.
  • Valutazioni critiche dei più recenti studi randomizzati controllati ad alto impatto e delle revisioni sistematiche in ortopedia.
  • Accesso ai contenuti del podcast OrthoEvidence, tra cui collaborazioni con il Journal of Bone and Joint Surgery, interviste con chirurghi di fama internazionale e tavole rotonde su notizie e argomenti ortopedici.
  • Abbonamento a The Pulse, una newsletter bisettimanale basata sulle evidenze scientifiche, progettata per aiutarla a prendere decisioni cliniche migliori.
Upgrade
Close Dialog
Bentornato!
Ha dimenticato la password?
Inizi la sua prova gratuita oggi stesso!

Il suo account sarà affiliato a
e includerà l'accesso gratuito a OrthoEvidence


O
Ha dimenticato la password?

O
Controlli la sua e-mail

Se esiste un account con l'indirizzo e-mail fornito, le verrà inviata un'e-mail di reimpostazione della password. Se non vede l'e-mail, controlli la cartella spam o posta indesiderata.

Per ulteriore assistenza, contatti il nostro team di supporto.

Effettui il login per abilitare questa funzione

Per accedere a questa funzione, deve essere collegato ad un account OrthoEvidence attivo. Effettui il login o crei un account di prova GRATUITO.

Tradurre il Rapporto ACE

OrthoEvidence utilizza un servizio di traduzione di terze parti per rendere i contenuti accessibili in più lingue. Si prega di notare che, sebbene venga fatto ogni sforzo per garantire l'accuratezza, le traduzioni potrebbero non essere sempre perfette.

Come citare questo documento ACE Report

OrthoEvidence. Radiostereometric analysis: no additional benefit of Unique femoral stem compared to AGB-I. OE Journal. 2014;2(13):9. Available from: https://myorthoevidence.com/AceReport/Show/radiostereometric-analysis-no-additional-benefit-of-unique-femoral-stem-compared-to-agb-i

Copiare la citazione
Effettui il login per abilitare questa funzione

Per accedere a questa funzione, deve essere collegato ad un account OrthoEvidence attivo. Effettui il login o crei un account di prova GRATUITO.

Funzionalità per i membri Premium

Per accedere a questa funzione, deve essere collegato ad un account OrthoEvidence Premium.

Condividi questo articolo ACE Report